Inactivation of hantaan virus-containing samples for subsequent investigations outside biosafety level 3 facilities

被引:37
作者
Kraus, AA [1 ]
Priemer, C [1 ]
Heider, H [1 ]
Krüger, DH [1 ]
Ulrich, R [1 ]
机构
[1] Univ Med Berlin, Inst Virol, Charite, DE-10117 Berlin, Germany
关键词
biosafety laboratory; cell culture; hantavirus; virus inactivation;
D O I
10.1159/000084603
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objectives: The potential risk of accidental infection by hantaviruses in a clinical or research laboratory necessitates special precautionary measures. A biosafety program must address handling and disposal of infectious materials as well as appropriate virus inactivation or depletion procedures to permit necessary further processing of specimens outside the biosafety level 3 laboratory. Methods: To study the elimination of hantavirus infectivity, the effects of different chemical and physical inactivation and depletion procedures were investigated on Hantaan virus- containing materials. An infectivity assay for hantaviruses was utilised to verify these procedures which are commonly preceding investigations such as ELISA, flow cytometry analysis, Western blot or immunofluorescence assay. Results: Chemical inactivation with methanol, paraformaldehyde, acetone/methanol and detergent-containing lysis buffer as well as physical forces such as UV irradiation and filtration efficiently reduced viral infectivity in infected cells and their supernatants below the detection limit. Conclusion: The virus inactivation and depletion methods described herein are suitable to prepare non-infectious samples for further use in immunological, virological and cell-biological assays. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 21 条
[1]   Inactivation of classical swine fever virus: association of hydrostatic pressure and ultraviolet irradiation [J].
Freitas, TRP ;
Gaspar, LP ;
Caldas, LA ;
Silva, JL ;
Rebello, MA .
JOURNAL OF VIROLOGICAL METHODS, 2003, 108 (02) :205-211
[2]   Virus safety of human blood, plasma, and derived products [J].
Guertler, LG .
THROMBOSIS RESEARCH, 2002, 107 :S39-S45
[3]   A chemiluminescence detection method of hantaviral antigens in neutralisation assays and inhibitor studies [J].
Heider, H ;
Ziaja, B ;
Priemer, C ;
Lundkvist, Å ;
Neyts, J ;
Krüger, DH ;
Ulrich, R .
JOURNAL OF VIROLOGICAL METHODS, 2001, 96 (01) :17-23
[4]   A lethal disease model for hantavirus pulmonary syndrome [J].
Hooper, JW ;
Larsen, T ;
Custer, DM ;
Schmaljohn, CS .
VIROLOGY, 2001, 289 (01) :6-14
[5]  
Johnson KM, 2001, CURR TOP MICROBIOL, V256, P1
[6]  
Kasermann F, 1998, REV MED VIROL, V8, P143
[7]   Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses [J].
Kraus, AA ;
Raftery, MJ ;
Giese, T ;
Ulrich, R ;
Zawatzky, R ;
Hippenstiel, S ;
Suttorp, N ;
Krüger, DH ;
Schönrich, G .
JOURNAL OF VIROLOGY, 2004, 78 (12) :6143-6150
[8]   Hantavirus infections and their prevention [J].
Krüger, DH ;
Ulrich, R ;
Lundkvist, Å .
MICROBES AND INFECTION, 2001, 3 (13) :1129-1144
[9]  
Krull M, 1996, J IMMUNOL, V157, P4133
[10]   ISOLATION OF ETIOLOGIC AGENT OF KOREAN HEMORRHAGIC-FEVER [J].
LEE, HW ;
LEE, PW ;
JOHNSON, KM .
JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (03) :298-308